- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02279290
Using CBT to Probe Psychobiobehavioral Resilience to Post-trauma Psychopathology
June 9, 2021 updated by: Alyson Zalta, Rush University Medical Center
This randomized controlled trial uses a modularized cognitive behavioral resilience training (MCBRT) intervention to probe risk and resilience mechanisms linked to post-trauma psychopathology.
Ninety participants with a history of interpersonal trauma during childhood or adolescence and mild to moderate distress will be randomized to MCBRT or a health education control condition.
The primary aims of this proposal are to examine whether individuals who receive MCBRT demonstrate increases in psychological resilience, biological resilience, and extinction learning compared to those in the control group.
This study will also explore associations between these psychobiobehavioral risk and resilience factors.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
58
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Rush University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 years of age or older
- fluent in English
- history of childhood interpersonal trauma (e.g., sexual assault, physical assault, witnessing assault before age 18)
- mild to moderate distress indicated by a score of 10-20 on the depression scale, 8-14 on the anxiety scale, or 15-25 on the stress scale of the DASS-21.
Exclusion Criteria:
- severe distress indicated by a score >20 on the depression scale, >14 on the anxiety scale, or >25 on the stress scale of the DASS-21
- DSM-5 criterion A trauma in the past month
- color blindness based on self-report (because of inability to complete the fear conditioning task)
- auditory impairment based on audiometer screening (because of inability to complete the fear conditioning task)
- lifetime psychotic or bipolar disorder
- substance abuse or dependence within past 6 months
- concurrent psychotherapy initiated within 3 months of randomization
- ongoing psychotherapy of any duration directed toward treatment of trauma-related psychopathology (e.g., CBT)
- must be on a stable dose of psychotropic or adrenergically-active medications (e.g., beta blockers) for at least 6 weeks prior to eligibility screening
- mental retardation or significant cognitive impairment
- serious medical illness or instability for which hospitalization may be likely within the next year
- significant suicidal ideation indicated by "yes" on Columbia Suicide Severity Rating Scale item 4 (active suicidal ideation with some intent to act) or enacted suicidal behaviors within 6 months prior to eligibility
- current legal actions related to trauma.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Healthy Mind Intervention (HMI)
This intervention will focus on teaching individuals a way to manage acute and chronic stressors more effectively.
|
Healthy Mind Intervention (HMI) is a flexible cognitive-behavioral resilience building program.
Participants will receive 8 weekly, 60-minute individual sessions of HMI.
In HMI, participants will be able to select 3 areas of resilience that they want to work on.
|
|
Active Comparator: Healthy Body Intervention (HBI)
This intervention will focus on important health-related topics.
|
The 8 weekly, 60-minute individual sessions will include the following topics: the mind-body connection, nutrition, exercise, unhealthy substances, sleep, preventing illness, and preventive care.
Each session is spent providing didactic information on these topics and strategies for how to engage in behavior change in these areas.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychological resilience outcomes include emotion regulation (DERS), hardiness (CD-RISC), optimism (LOT-R), perceived control (SMS), social support (MSPSS), and task-oriented coping (CISS-SFT).
Time Frame: 0 - 9 weeks
|
Difference between the interventions in the change of psychological resilience from pre to post intervention.
|
0 - 9 weeks
|
|
Biological resilience outcomes include neuropeptide Y [NPY], dehydroepiandrosterone [DHEA], allopregnanolone [ALLO] taken from a blood draw.
Time Frame: 0-9 weeks
|
Difference between the interventions in the change of biological resilience from pre to post intervention.
|
0-9 weeks
|
|
Extinction learning will be analyzed using the fear potentiated startle data from a fear conditioning paradigm.
Time Frame: 0-9 weeks
|
Difference between the interventions in the change of extinction learning from pre to post intervention.
|
0-9 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Alyson K Zalta, PhD, Rush University Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 13, 2015
Primary Completion (Actual)
November 14, 2018
Study Completion (Actual)
April 26, 2019
Study Registration Dates
First Submitted
October 22, 2014
First Submitted That Met QC Criteria
October 28, 2014
First Posted (Estimate)
October 31, 2014
Study Record Updates
Last Update Posted (Actual)
June 11, 2021
Last Update Submitted That Met QC Criteria
June 9, 2021
Last Verified
June 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- K23MH103394 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Healthy Mind Intervention (HMI)
-
University of WashingtonAsian American Resource and Information Network, Inc.CompletedDepression | Sleep | Anxiety Depression | Mindfulness Based Cognitive TherapyUnited States
-
Burdur Mehmet Akif Ersoy UniversityCompletedAlzheimer Disease | Aging | Cognitive DeclineTurkey (Türkiye)
-
University of Wisconsin, MadisonCompletedUrinary Incontinence | Fecal Incontinence | Accidental Bowel Leakage
-
University of Colorado, BoulderCompletedEating Disorders in AdolescenceUnited States
-
The University of New South WalesRecruitingOsteoarthritis | Cognitive DeclineAustralia
-
University of Wisconsin, MadisonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Wisconsin...CompletedUrinary Incontinence in Old Age | Fecal Incontinence in Old AgeUnited States
-
University of Illinois at ChicagoNational Institute on Aging (NIA)Completed
-
University of Wisconsin, MadisonCompletedIncontinence, Urinary | Incontinence BowelUnited States
-
Penn State UniversityJohns Hopkins Bloomberg School of Public Health; University of North Carolina... and other collaboratorsCompletedStress | Anxiety | Depression Symptoms | Externalizing SymptomsUnited States
-
Beth Israel Deaconess Medical CenterRecruiting